Avricore Health (AVCRF) Capital Expenditures (2009 - 2025)

Avricore Health has disclosed Capital Expenditures across 10 years of filings, most recently posting -$61285.8 for Q3 2025.

• In Q3 2025, Capital Expenditures rose 52.43% year-over-year to -$61285.8; the TTM figure through Sep 2025 stood at -$286182.4 (up 44.66% YoY), while the FY2025 annual figure was -$63339.2, up 52.11% from the prior year.
• Capital Expenditures slipped to -$61285.8 in Q3 2025, from -$49497.2 in the prior quarter.
• Over the last five years, Capital Expenditures for AVCRF reached as high as $1.4 million in Q4 2022 and fell as low as -$465996.9 in Q3 2022.
• The 5-year median for Capital Expenditures is -$59072.5 (2025), against an average of -$7490.2.
• The widest YoY moves for Capital Expenditures: up 789.45% in 2022, down 926.92% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $162130.9 in 2021, then soared by 789.45% to $1.4 million in 2022, then tumbled by 117.49% to -$252185.1 in 2023, then surged by 48.91% to -$128834.1 in 2024, then surged by 52.43% to -$61285.8 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered -$61285.8, -$49497.2, and -$46565.2 for Q3 2025, Q2 2025, and Q1 2025 respectively.